Mechanisms of PGRMC1 Action in Endometrial Proliferation
PGRMC1 在子宫内膜增殖中的作用机制
基本信息
- 批准号:9182394
- 负责人:
- 金额:$ 19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-07-29 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Project Summary/Abstract
PGRMC1 is expressed in the human endometrium at highest levels during the estrogen dominated proliferative
phase, suggesting that this relatively uncharacterized protein functions to coordinate epithelial cell proliferation.
Our lab recently floxed the murine Pgrmc1 gene in an effort to evaluate the function of this gene in the context
of female fertility. Conditional mutagenesis studies using Pgr-cre mice revealed that PGRMC1 is necessary for
the expression of several growth factors and subsequent epithelial cell proliferation in response to estradiol
(E2). IGF-1, for example, is well-established as a growth factor produced in the endometrial stromal
compartment in response to E2 that in turn binds to its cognate receptor on epithelial cells and drives
proliferation. Based on these novel findings, the central hypothesis of this application is that PGRMC1 is
essential for E2-induced endometrial epithelial cell proliferation and over-expression of PGRMC1 elevates E2-
induced proliferative responses in the endometrium. A likely and expected consequence of PGRMC1 over-
expression is the elevated production of growth factors that would promote development and progression
toward endometrial cancer. Indeed, epidemiological studies support the concept that high adult body mass
index, which results in elevated systemic estrone, and postmenopausal hormone replacement therapy,
particularly unopposed E2 taken for an extended period of time, are solid risk factors for Type 1 E2-dependent
endometrial cancers. The goal of this application is to investigate the molecular mechanisms by which
PGRMC1 functions in the regulation of E2 signal transduction and production of paracrine growth factors that
promote endometrial proliferation. Identifying PGRMC1-interacting proteins is a central objective and this will
help establish PGRMC1 mechanism of action. A fundamental understanding of how estradiol (E2) signals is
necessary for advancing reproductive biology and for developing strategies to combat hyperproliferative
diseases of the endometrium such as endometriosis and endometrial cancer.
项目摘要/摘要
PGRMC1在雌激素中以最高水平的增生为主的人子宫内膜中表达
相位,表明这种相对未表征的蛋白质功能可以协调上皮细胞增殖。
我们的实验室最近对鼠PGRMC1基因进行了努力,以评估该基因在上下文中的功能
女性生育能力。使用PGR-CRE小鼠的条件诱变研究表明,PGRMC1对于
几种生长因子的表达以及随后对雌二醇的上皮细胞增殖的表达
(E2)。例如,IGF-1作为子宫基质中产生的生长因子的建立良好
响应于E2的隔室又与其上皮细胞上的同源受体结合并驱动
增殖。基于这些新颖的发现,该应用的中心假设是PGRMC1是
对于E2诱导的子宫内膜上皮细胞增殖至关重要,PGRMC1的过表达升高E2-
子宫内膜中诱导的增生反应。 PGRMC1过度的可能和预期的结果
表达是增长因子的产生升高,可以促进发展和发展
迈向子宫内膜癌。实际上,流行病学研究支持了高成年体重的概念
指数导致全身雌酮升高和绝经后激素替代疗法,
特别是无反对的E2长期服用,是1型E2依赖性的固体风险因素
子宫内膜癌。该应用的目的是研究分子机制
PGRMC1在E2信号转导和旁分泌生长因子的产生中起作用
促进子宫内膜增殖。识别PGRMC1相互作用蛋白是一个核心目标,这将
帮助建立PGRMC1作用机理。对雌二醇(E2)信号的基本了解
推进生殖生物学和制定策略以对抗超增殖性超增强的必要
子宫内膜疾病,例如子宫内膜异位症和子宫内膜癌。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

暂无数据
数据更新时间:2024-06-01
James K Pru的其他基金
PGRMC Proteins as Markers of Fertility and Overall Health Status
PGRMC 蛋白作为生育力和整体健康状况的标志
- 批准号:1072906810729068
- 财政年份:2023
- 资助金额:$ 19万$ 19万
- 项目类别:
Regulation of endometrial proliferation by the PGRMC family
PGRMC 家族对子宫内膜增殖的调节
- 批准号:1021117110211171
- 财政年份:2021
- 资助金额:$ 19万$ 19万
- 项目类别:
Regulation of endometrial proliferation by the PGRMC family
PGRMC 家族对子宫内膜增殖的调节
- 批准号:1038377810383778
- 财政年份:2021
- 资助金额:$ 19万$ 19万
- 项目类别:
Regulation of endometrial proliferation by the PGRMC family
PGRMC 家族对子宫内膜增殖的调节
- 批准号:1061335010613350
- 财政年份:2021
- 资助金额:$ 19万$ 19万
- 项目类别:
Mechanisms of PGRMC2 action in female reproduction
PGRMC2 在女性生殖中的作用机制
- 批准号:87016678701667
- 财政年份:2014
- 资助金额:$ 19万$ 19万
- 项目类别:
Mechanisms of PGRMC2 action in female reproduction
PGRMC2 在女性生殖中的作用机制
- 批准号:88430608843060
- 财政年份:2014
- 资助金额:$ 19万$ 19万
- 项目类别:
Uterine Vascular Remodeling during Pregnancy
妊娠期子宫血管重塑
- 批准号:85092388509238
- 财政年份:2013
- 资助金额:$ 19万$ 19万
- 项目类别:
Uterine Vascular Remodeling during Pregnancy
妊娠期子宫血管重塑
- 批准号:86803818680381
- 财政年份:2013
- 资助金额:$ 19万$ 19万
- 项目类别:
Functional Analysis of Endometrial Stem/Progenitor Cells
子宫内膜干/祖细胞的功能分析
- 批准号:79784547978454
- 财政年份:2010
- 资助金额:$ 19万$ 19万
- 项目类别:
Functional Analysis of Endometrial Stem/Progenitor Cells
子宫内膜干/祖细胞的功能分析
- 批准号:81002288100228
- 财政年份:2010
- 资助金额:$ 19万$ 19万
- 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA
患有镰状细胞性贫血的初潮后女性的卵巢储备
- 批准号:1069020010690200
- 财政年份:2022
- 资助金额:$ 19万$ 19万
- 项目类别:
Wnt Pathway Regulation of Gastric Stem Cell Function
胃干细胞功能的 Wnt 通路调控
- 批准号:1055712010557120
- 财政年份:2022
- 资助金额:$ 19万$ 19万
- 项目类别:
Wnt Pathway Regulation of Gastric Stem Cell Function
胃干细胞功能的 Wnt 通路调控
- 批准号:1036485910364859
- 财政年份:2022
- 资助金额:$ 19万$ 19万
- 项目类别:
OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA
患有镰状细胞性贫血的初潮后女性的卵巢储备
- 批准号:1047370410473704
- 财政年份:2020
- 资助金额:$ 19万$ 19万
- 项目类别:
OVARIAN RESERVE IN POST-MENARCHAL FEMALES WITH SICKLE CELL ANEMIA
患有镰状细胞性贫血的初潮后女性的卵巢储备
- 批准号:1005502210055022
- 财政年份:2020
- 资助金额:$ 19万$ 19万
- 项目类别: